Insider · CIK 0001298416
David Jeffs
Files at STME (Cell MedX Corp.). First filing Jan 10, 2024, latest Jan 10, 2024.
In brief
David Jeffs files SEC Form 4 as CEO, director and 10% owner at STME (Cell MedX Corp.). Since Jan 10, 2024, David Jeffs has reported 1 open-market buy worth $105k and 0 open-market sells worth $0, the latest filed on Jan 10, 2024.
A track record needs three past buys with six months of prices behind them; David Jeffs has 0, so none is measured yet.
The newest scored trade: bought $105k of STME on Dec 29, 2023, filed Jan 10, 2024, scored 57 (moderate).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
STME: Cell MedX Corp.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 57Moderate | Cell MedX Corp. | $105k 15,000,000 shares | +20% | +238% from low-57% from high |
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 29, 2023 | STME Cell MedX Corp. | AGrant or award Common Shares | +73,959,726 | $0.01 | $518k | 73,959,726 | Jan 10, 2024 |
| Dec 29, 2023 | STME Cell MedX Corp. | POpen-market purchase Common Sharesindirect: Daughter | +7,500,000 | $0.01 | $53k | 81,459,726 | Jan 10, 2024 |
| Dec 29, 2023 | STME Cell MedX Corp. | POpen-market purchase Common Sharesindirect: Son | +7,500,000 | $0.01 | $53k | 88,959,726 | Jan 10, 2024 |
Questions about David Jeffs
Answered from the filings on this page, as of the latest one.
Is David Jeffs buying or selling?
Not in the last 12 months. David Jeffs's latest open-market trade on SEC Form 4 was bought $105k of STME on Dec 29, 2023.
How did David Jeffs's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and David Jeffs has 0.
Where does David Jeffs file Form 4?
David Jeffs has filed Form 4 at STME (Cell MedX Corp.) as Chief Executive Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.